Literature DB >> 6517542

Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.

H Hof, M Rieffert, V Sticht-Groh, O Zak, E H Schweizer.   

Abstract

Niridazole (Ambilhar) and three other newly synthesized nitrothiazole derivatives were highly active against 19 microaerophilic campylobacters (minimum concentration required to inhibit 50% of strains [MIC50], 0.0075 to 0.015 mg/liter). There were, however, considerable differences in the susceptibility among strains tested, and one nitrothiazole derivative was rather inactive (MIC50, 2 mg/liter). Nitroimidazole derivatives, such as metronidazole and tinidazole, were less active (MIC50, 2 and 4 mg/liter, respectively). The nitrofuran derivatives, such as nitrofurazone and nitrofurantoin, were also less active (MIC50, 1 mg/liter). Niridazole and another potent nitrothiazole derivative killed the campylobacters rapidly at low concentrations. In contrast, much higher concentrations of metronidazole were required to achieve bactericidal values.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6517542      PMCID: PMC179952          DOI: 10.1128/AAC.26.4.498

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

2.  Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.

Authors:  H Hof; V Sticht-Groh; K M Müller
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

3.  Trial of ambilhar, a nitrothiazole derivative, in S. mansoni infections in Tanzania.

Authors:  P Jordan
Journal:  Br Med J       Date:  1966-01-29

4.  Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.

Authors:  H Hof; V Sticht-Groh
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

5.  In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazole.

Authors:  A M Freydière; Y Gille; S Tigaud; P Vincent
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

6.  [Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria].

Authors:  H Hof; K M Müller
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1982-11

7.  Improved media for growth and aerotolerance of Campylobacter fetus.

Authors:  H A George; P S Hoffman; R M Smibert; N R Krieg
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

  7 in total
  4 in total

1.  Susceptibility of Campylobacter species to niridazole.

Authors:  R M Bannatyne; M A Karmali; J Jackowski; M Roscoe
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

2.  Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility.

Authors:  W J Page; G Huyer; M Huyer; E A Worobec
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

3.  Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria.

Authors:  H Hof; J Ströder; J P Buisson; R Royer
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

4.  Antimicrobial effects of niridazole on Gardnerella vaginalis.

Authors:  R M Bannatyne; J Jackowski
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.